Analyst Ratings for TherapeuticsMD (TXMD)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/10/2023 | Cantor Fitzgerald | Louise Chen | New Coverage | Neutral (N/A) |
5.00 (N/A) |
5.33 (1.87) |
-64.92% | Details |
| 6/7/2022 | H.C. Wainwright | N/A | Downgrade | Neutral (Buy) |
N/A (N/A) |
9.97 (1.87) |
-81.24% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
